Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Neuromyelitis optica.
Inhibition of Neuronal Degenerin/Epithelial Na+ Channels by the Multiple Sclerosis Drug 4-Aminopyridine.
Receptos provides update on progress of lead product candidate RPC1063
Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis.
A phase II study of laquinimod in Crohn's disease.
Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis.
A genome screen for multiple sclerosis in Italian families.
Comprehending the inexplicable: qualitative accounts of black Caribbean and white british people severely affected by multiple sclerosis.
The value of specialty pharmaceuticals - a systematic review.
Animal Models in Neurology: Drawbacks and Opportunities.
Progress in multiple sclerosis research in the last year.
Sexual dysfunction ın multiple sclerosis: Gender differences.
Fingolimod Therapy in Early Multiple Sclerosis: An Efficacy Analysis of the TRANSFORMS and FREEDOMS Studies by Time Since First Symptom.
Improvement of internuclear ophthalmoparesis in multiple sclerosis with dalfampridine.
[Optical coherence tomography in multiple sclerosis].
MP2RAGE Multiple Sclerosis Magnetic Resonance Imaging at 3 T.
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis.
Santhera receives first product approval: Health Canada approves Catena® for treatment of Friedreich's ataxia
Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases.
Safety Study of GNbAC1 in Multiple Sclerosis Patients
Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis.
Memory rehabilitation for people with multiple sclerosis.
Early activation of CD4+ and CD8+ T lymphocytes by myelin basic protein in subjects with MS.
Norovirus-related chronic diarrhea in a patient treated with alemtuzumab for chronic lymphocytic leukemia.
Neuronal NF-κB ablation does not influence neuro-axonal degeneration in experimental autoimmune demyelination.

Pages